AIMT
Aimmune Therapeutics
AIMT
AIMT
Delisted
AIMT was delisted on the 12th of October, 2020.
96 hedge funds and large institutions have $757M invested in Aimmune Therapeutics in 2017 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 45 increasing their positions, 21 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
2% less capital invested
Capital invested by funds: $771M → $757M (-$13.5M)
Holders
96
Holding in Top 10
5
Calls
$252K
Puts
–
Top Buyers
| 1 | +$14.8M | |
| 2 | +$13.5M | |
| 3 | +$9.7M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$6.46M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$6.43M |
Top Sellers
| 1 | -$50.3M | |
| 2 | -$9.85M | |
| 3 | -$8.99M | |
| 4 |
TG
TLP Group
Evanston,
Illinois
|
-$2.06M |
| 5 |
AG
Artal Group
Luxembourg
|
-$1.68M |